The novel coronavirus, COVID-19, has been declared a pandemic by the World Health Organization (WHO). As it spreads, researchers are mobilizing to understand the virus’s binding mechanisms as a first step in the development of a vaccine.
In this application note, discover real-life examples of how bio-layer interferometry and biosensor technology is contributing to COVID-19 vaccine development, allowing researchers to assess virus-antibody interaction features such as:
